$DRIO
DarioHealth Corp. Stock $drio

$drio Overview Financials Valuation SEC Filings Company Website

2015 Q2 Form 10-Q Financial Statement

#000114420415048544 Filed on August 12, 2015

Income Statement

Concept	2015 Q2	2014 Q4	2014 Q2
Revenue	$175.0K	$50.00K	$0.00
YoY Change
Cost Of Revenue	$410.0K	$660.0K	$605.0K
YoY Change	-32.23%
Gross Profit	-$235.0K	-$610.0K	-$605.0K
YoY Change	-61.16%
Gross Profit Margin	-134.29%	-1220.0%
Selling, General & Admin	$840.0K	$750.0K	$1.670M
YoY Change	-49.7%	-60.73%	7.05%
% of Gross Profit
Research & Development	$441.0K	$730.0K	$1.333M
YoY Change	-66.92%	-58.05%	-5.86%
% of Gross Profit
Depreciation & Amortization	$80.00K	$90.00K	$160.0K
YoY Change	-50.0%	-65.38%	-15.79%
% of Gross Profit
Operating Expenses	$1.277M	$1.480M	$2.998M
YoY Change	-57.4%	-59.45%	-16.63%
Operating Profit	-$1.512M	-$2.090M	-$3.603M
YoY Change	-58.03%		0.19%
Interest Expense	-$490.0K	-$970.0K	$390.0K
YoY Change	-225.64%	-126.15%	-123.21%
% of Operating Profit
Other Income/Expense, Net	-$492.0K	-$10.00K	$349.0K
YoY Change	-240.97%		-120.65%
Pretax Income	-$2.000M	-$3.560M	-$3.250M
YoY Change	-38.46%	-7220.0%	-38.56%
Income Tax		$0.00	$0.00
% Of Pretax Income
Net Earnings	-$2.004M	-$3.560M	-$3.254M
YoY Change	-38.41%	-7220.0%	-38.44%
Net Earnings / Revenue	-1145.14%	-7120.0%
Basic Earnings Per Share	-$0.07		-$0.14
Diluted Earnings Per Share	-$0.07	-$89.00M	-$0.15
COMMON SHARES
Basic Shares Outstanding	30.24M shares	16.23M shares	22.99M shares
Diluted Shares Outstanding	30.24M shares		23.20M shares

Balance Sheet

Concept	2015 Q2	2014 Q4	2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.100M	$1.500M	$2.000M
YoY Change	-45.0%	-37.5%	-72.22%
Cash & Equivalents	$981.0K	$1.453M	$1.819M
Short-Term Investments	$100.0K	$100.0K	$200.0K
Other Short-Term Assets		$33.00K	$0.00
YoY Change		-36.54%
Inventory	$207.0K	$234.0K	$22.00K
Prepaid Expenses
Receivables	$0.00	$94.00K
Other Receivables	$300.0K
Total Short-Term Assets	$1.611M	$2.056M	$2.362M
YoY Change	-31.8%	-29.83%	-69.75%
LONG-TERM ASSETS
Property, Plant & Equipment	$854.0K	$978.0K	$991.0K
YoY Change	-13.82%	-14.59%	-33.33%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$0.00	$0.00	$0.00
YoY Change			-100.0%
Total Long-Term Assets	$894.0K	$1.025M	$1.040M
YoY Change	-14.04%	-13.58%	-34.76%
TOTAL ASSETS
Total Short-Term Assets	$1.611M	$2.056M	$2.362M
Total Long-Term Assets	$894.0K	$1.025M	$1.040M
Total Assets	$2.505M	$3.081M	$3.402M
YoY Change	-26.37%	-25.15%	-63.81%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$900.0K	$700.0K	$700.0K
YoY Change	28.57%	16.67%	0.0%
Accrued Expenses		$679.0K
YoY Change		14.89%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.546M	$1.616M	$1.776M
YoY Change	-12.95%	7.3%	33.84%
LONG-TERM LIABILITIES
Long-Term Debt	$2.400M	$2.800M	$0.00
YoY Change
Other Long-Term Liabilities	$4.400M	$4.000M	$5.400M
YoY Change	-18.52%	48.15%	-12.9%
Total Long-Term Liabilities	$6.800M	$6.800M	$5.400M
YoY Change	25.93%	151.85%	-12.9%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.546M	$1.616M	$1.776M
Total Long-Term Liabilities	$6.800M	$6.800M	$5.400M
Total Liabilities	$8.300M	$8.400M	$7.200M
YoY Change	15.28%	100.0%	-5.26%
SHAREHOLDERS EQUITY
Retained Earnings	-$39.85M	-$36.06M	-$26.24M
YoY Change	51.88%	80.26%
Common Stock	$3.000K	$2.000K	$2.000K
YoY Change	50.0%		0.2%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$5.777M	-$5.295M	-$3.800M
YoY Change
Total Liabilities & Shareholders Equity	$2.505M	$3.081M	$3.400M
YoY Change	-26.32%	-25.15%	-63.84%

Cashflow Statement

Concept	2015 Q2	2014 Q4	2014 Q2
OPERATING ACTIVITIES
Net Income	-$2.004M	-$3.560M	-$3.254M
YoY Change	-38.41%	-7220.0%	-38.44%
Depreciation, Depletion And Amortization	$80.00K	$90.00K	$160.0K
YoY Change	-50.0%	-65.38%	-15.79%
Cash From Operating Activities	-$1.300M	-$2.410M	-$2.080M
YoY Change	-37.5%	13.15%	1.46%
INVESTING ACTIVITIES
Capital Expenditures	-$10.00K	-$340.0K	-$30.00K
YoY Change	-66.67%	277.78%	-95.65%
Acquisitions
YoY Change
Other Investing Activities	-$10.00K	$40.00K	$20.00K
YoY Change	-150.0%	-166.67%	-111.11%
Cash From Investing Activities	-$20.00K	-$300.0K	-$10.00K
YoY Change	100.0%	87.5%	-98.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	450.0K	0.000	100.0K
YoY Change	350.0%	-100.0%	-98.96%
NET CHANGE
Cash From Operating Activities	-1.300M	-2.410M	-2.080M
Cash From Investing Activities	-20.00K	-300.0K	-10.00K
Cash From Financing Activities	450.0K	0.000	100.0K
Net Change In Cash	-870.0K	-2.710M	-1.990M
YoY Change	-56.28%	22.07%	-129.57%
FREE CASH FLOW
Cash From Operating Activities	-$1.300M	-$2.410M	-$2.080M
Capital Expenditures	-$10.00K	-$340.0K	-$30.00K
Free Cash Flow	-$1.290M	-$2.070M	-$2.050M
YoY Change	-37.07%	1.47%	50.74%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015Q2	us-gaap	Common Stock Value CommonStockValue	3000	USD
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	2000	USD
CY2015Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2014Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	34074000	USD
CY2014Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	30761000	USD
CY2015Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-39854000	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-36058000	USD
CY2015Q2	us-gaap	Stockholders Equity StockholdersEquity	-5777000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	-5295000	USD
CY2015Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2505000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3081000	USD
CY2015Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	2357000	USD
CY2014Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	2757000	USD
CY2015Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	78000	USD
CY2014Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	24000	USD
CY2014Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1333000	USD
CY2015Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	441000	USD
CY2014Q2	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	373000	USD
CY2015Q2	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	262000	USD
CY2014Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1292000	USD
CY2015Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	574000	USD
CY2014Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-3603000	USD
CY2015Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1512000	USD
CY2014Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-47000	USD
CY2015Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	34000	USD
CY2015Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-492000	USD
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	-2004000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1453000	USD
CY2015Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	981000	USD
CY2014Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	0	USD
CY2015Q2	us-gaap	Inventory Net InventoryNet	207000	USD
CY2015Q2	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	3000	USD
CY2015Q2	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	856000	USD
CY2014Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	708000	USD
CY2015Q2	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	612000	USD
CY2014Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	884000	USD
CY2015Q2	us-gaap	Liabilities Current LiabilitiesCurrent	1546000	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1616000	USD
CY2015Q2	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	4379000	USD
CY2014Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	4003000	USD
CY2014Q4	us-gaap	Inventory Net InventoryNet	234000	USD
CY2015Q2	us-gaap	Short Term Investments ShortTermInvestments	92000	USD
CY2014Q4	us-gaap	Short Term Investments ShortTermInvestments	83000	USD
CY2015Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	328000	USD
CY2014Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	286000	USD
CY2015Q2	us-gaap	Assets Current AssetsCurrent	1611000	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	2056000	USD
CY2015Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	40000	USD
CY2014Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	47000	USD
CY2015Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	854000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	978000	USD
CY2015Q2	us-gaap	Assets Assets	2505000	USD
CY2014Q4	us-gaap	Assets Assets	3081000	USD
CY2015Q2	us-gaap	Gross Profit GrossProfit	-235000	USD
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	400000	USD
CY2014Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	349000	USD
CY2014Q2	us-gaap	Net Income Loss NetIncomeLoss	-3254000	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	175000	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-163000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-2832000	USD
	us-gaap	Payments For Proceeds From Loans Receivable PaymentsForProceedsFromLoansReceivable	0	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-538000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	376000	USD
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	3000	USD
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	0	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	54000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	0	USD
CY2015Q2	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	200000	USD
CY2014Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	68000	USD
CY2015Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	7000	USD
CY2014Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	166000	USD
CY2015Q2	us-gaap	Revenues Revenues	175000	USD
CY2015Q2	us-gaap	Cost Of Revenue CostOfRevenue	410000	USD
CY2014Q2	us-gaap	Operating Expenses OperatingExpenses	2998000	USD
CY2015Q2	us-gaap	Operating Expenses OperatingExpenses	1277000	USD
CY2014Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-396000	USD
CY2015Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	526000	USD
CY2014	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	0	USD
CY2014	drio	Deemed Dividend Related To Exchange Agreement Adjustment DeemedDividendRelatedToExchangeAgreementAdjustment	0	USD
CY2014	drio	Stock Issued During Period Value Upon Exchange Agreement StockIssuedDuringPeriodValueUponExchangeAgreement	4558000	USD
CY2014	drio	Deemed Dividend Related To Preferred Stock DeemedDividendRelatedToPreferredStock	0	USD
CY2014	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	46000	USD
CY2014	drio	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	352000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	USD
CY2014	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	7000	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	212000	USD
CY2014	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1692000	USD
CY2014	us-gaap	Net Income Loss NetIncomeLoss	-12877000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-3642000	USD
	drio	Stock Issued During Period Value New Issues April And May2013 StockIssuedDuringPeriodValueNewIssuesAprilAndMay2013	1956000	USD
CY2014	drio	Stock Issued During Period Value New Issues February2014 StockIssuedDuringPeriodValueNewIssuesFebruary2014	1013000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-6238000	USD
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	1199000	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	489000	USD
	us-gaap	Depreciation Depreciation	358000	USD
	drio	Increase Decrease In Accounts Receivables And Prepaid Expense IncreaseDecreaseInAccountsReceivablesAndPrepaidExpense	-120000	USD
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	39000	USD
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	6000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	134650	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	98225	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.01
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	7.07
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	23000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-505000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	33000	USD
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	4.14
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1317400	shares
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1078525	shares
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	1055813	shares
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	943900	shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.59
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.58
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	6.58
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	6.70
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	8000	USD
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	12000	USD
CY2015Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	12000	USD
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	12000	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P6Y11M19D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y8M19D
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y11M23D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y11M26D
	drio	Bank Charges BankCharges	7000	USD
	drio	Bank Charges BankCharges	4000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-9000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	27000	USD
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	489000	USD
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	0	USD
	us-gaap	Revenues Revenues	242000	USD
	us-gaap	Revenues Revenues	0	USD
	us-gaap	Cost Of Revenue CostOfRevenue	707000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	1026000	USD
	us-gaap	Gross Profit GrossProfit	-465000	USD
	us-gaap	Gross Profit GrossProfit	-1026000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1324000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2440000	USD
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	514000	USD
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	659000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	986000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2146000	USD
	us-gaap	Operating Expenses OperatingExpenses	5245000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3289000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-6271000	USD
CY2015Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2158000	USD
CY2014Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3254000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3796000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-6238000	USD
CY2015Q2	drio	Deemed Dividend Related To Exchange Agreement DeemedDividendRelatedToExchangeAgreement	154000	USD
CY2014Q2	drio	Deemed Dividend Related To Exchange Agreement DeemedDividendRelatedToExchangeAgreement	0	USD
	drio	Deemed Dividend Related To Exchange Agreement DeemedDividendRelatedToExchangeAgreement	154000	USD
	drio	Deemed Dividend Related To Exchange Agreement DeemedDividendRelatedToExchangeAgreement	0	USD
CY2015Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2014Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
CY2015Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30243041	shares
CY2014Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22985523	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25845711	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22152675	shares
CY2015Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2014Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.29
CY2015Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30243041	shares
CY2014Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23202077	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25845711	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22260952	shares
CY2015Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2015Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	160000000	shares
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2015Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	31476212	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	16233430	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	16233430	shares
CY2015Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	31476212	shares
CY2015Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2014Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2015Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	4940000	shares
CY2014Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	4940000	shares
CY2015Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2014Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2014Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	29000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-27000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	22000	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	10000	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	130000	USD
CY2015Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
	us-gaap	Inventory Write Down InventoryWriteDown	106000	USD
CY2014	us-gaap	Inventory Write Down InventoryWriteDown	1046000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	212000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1199000	USD
	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	6052	shares
CY2014Q3	drio	Preferred Stock Converted Into Common Stock At Ratio PreferredStockConvertedIntoCommonStockAtRatio	1,526,609
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	8000	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	USD
	drio	Deemed Dividend Inducement Of Warrant Exercise In May2015 DeemedDividendInducementOfWarrantExerciseInMay2015	0	USD
CY2015Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	1923636	shares
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	453000	USD
CY2015Q2	drio	Deemed Dividend Inducement Of Warrant Exercise In May2015 DeemedDividendInducementOfWarrantExerciseInMay2015	154000	USD
CY2015Q2	drio	Stock Issued During Period Warrants Exercised StockIssuedDuringPeriodWarrantsExercised	1923636	shares
	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	110000	USD
CY2015Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q3	us-gaap	Preferred Units Issued PreferredUnitsIssued	42350	shares
	drio	Preferred Stock Converted Into Common Stock At Ratio PreferredStockConvertedIntoCommonStockAtRatio	ratio of 1 to 252
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-49000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-130000	USD
	drio	Proceeds From Issuance Of Common Stock And Warrants ProceedsFromIssuanceOfCommonStockAndWarrants	1956000	USD
	drio	Proceeds From Issuance Of Common Stock And Warrants ProceedsFromIssuanceOfCommonStockAndWarrants	3754000	USD
	drio	Proceeds From Stock Options And Warrants Exercised ProceedsFromStockOptionsAndWarrantsExercised	350000	USD
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	453000	USD
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	2409000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	4104000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-472000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-444000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2263000	USD
CY2014Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1819000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	24000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	56000	USD
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	9000	USD
	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	0	USD
CY2015Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	272000	USD
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P5M23D
	drio	Stock Issued During Period Value Conversion Of Warrants StockIssuedDuringPeriodValueConversionOfWarrants	453000	USD
	us-gaap	Payments To Acquire Leases Held For Investment PaymentsToAcquireLeasesHeldForInvestment	-7000	USD
	us-gaap	Payments To Acquire Leases Held For Investment PaymentsToAcquireLeasesHeldForInvestment	8000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	46000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	150000	USD
	drio	Proceeds From Stock Options And Warrants Exercised ProceedsFromStockOptionsAndWarrantsExercised	0	USD
	us-gaap	Revenue Recognition Software RevenueRecognitionSoftware	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"> <tr> <td style="BORDER-BOTTOM-COLOR: #000000; PADDING-BOTTOM: 0in; BORDER-TOP-COLOR: #000000; PADDING-LEFT: 0in; WIDTH: 27pt; PADDING-RIGHT: 0in; BORDER-RIGHT-COLOR: #000000; BORDER-LEFT-COLOR: #000000; PADDING-TOP: 0in" valign="top" width="36"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt"> <font style="FONT-SIZE: 10pt">a.</font></div> </td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt" align="justify"><font style="FONT-SIZE: 10pt">Revenue recognition:</font></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 85.5pt" align="justify"><font style="FONT-SIZE: 10pt">Revenues from product sales are recognized in accordance with ASC 605-10 "Revenue Recognition", when delivery has occurred, persuasive evidence of an agreement exists, the vendor’s fee is fixed or determinable, no further obligation exists and collectability is probable.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 112.5pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 85.05pt" align="justify"><font style="FONT-SIZE: 10pt">The Company derives revenues from the sale of its Dario Smart Meter and its related device-specific disposables test strip cartridges and lancets through independent distributers or directly to end users. The Dario software application is offered for a free download and the Company does not obtain a recurring hosting commitment towards the end users relating specifically to the application.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt 85.5pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 85.05pt" align="justify"><font style="FONT-SIZE: 10pt">The Company generally has a standard contract with its distributors. According to the agreements, all sales to distributors are final, no rights of return or price protection right is granted to such distributors and the Company is not a party of the agreements between distributors and their customers. </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 85.05pt" align="justify"><font style="FONT-SIZE: 10pt"></font><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 85.05pt" align="justify"><font style="FONT-SIZE: 10pt">Through June 30, 2015, product sales to distributors are recognized as revenues upon receipt of payment. The Company will apply this policy until it will have sufficient historical experience with each distributor in order to conclude that fee is fixed or determinable and collectability is probable.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 112.5pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 85.5pt" align="justify"><font style="FONT-SIZE: 10pt">The Company also generates revenues from arrangements with health care providers which include supply of Dario Smart Meters and software platform that requires certain customization followed by monthly service, support and maintenance.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 85.05pt" align="justify"><font style="FONT-SIZE: 10pt">When a sales arrangement contains multiple elements, such as software and non-software components, the Company allocates revenue to each element based on a selling price hierarchy as required according to ASC 605-25, "Multiple-Element Arrangements".  The selling price for a deliverable is based on its Vendor Specific Objective Evidence ("VSOE"), if available, third party evidence ("TPE") if VSOE is not available, or estimated selling price ("ESP") if neither VSOE nor TPE is available. The best estimate of selling price is established considering several internal factors including, but not limited to, historical sales, pricing practices and geographies in which the Company offers its products. The determination of ESP is judgmental.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 85.05pt" align="justify"><font style="FONT-SIZE: 10pt">  <b>   </b></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 85.05pt" align="justify"><font style="FONT-SIZE: 10pt">Revenues from software components in sales arrangement contains multiple elements are recognized when all criteria outlined in ASC 985-605, "Software Revenue Recognition" ("ASC 985-605"), are met. Revenue from services is recognized when persuasive evidence of an arrangement exists, delivery of the product has occurred or the services have been rendered, the fee is fixed or determinable and collectability is probable.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 85.05pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 85.05pt" align="justify"><font style="FONT-SIZE: 10pt">For multiple element arrangements within ASC 985-605, revenues are allocated to the different elements in the arrangement under the "residual method" when VSOE of fair value exist for all undelivered elements and no VSOE exists for the delivered elements. Under the residual method, at the outset of the arrangement with the customer, the fair value of the undelivered elements is deferred and the remaining portion of the arrangement fee is allocated to the delivered elements and is recognized as revenue when the basic criteria in ASC 985-605 have been met. Any discount in the arrangement is allocated to the delivered element.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 85.05pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 85.05pt" align="justify"><font style="FONT-SIZE: 10pt">Since VSOE does not exist for undelivered elements, revenues are recognized as one unit of accounting, on a straight-line basis over the term of the last deliverable based on ASC 605-15, “Products” and ASC 985-605.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 85.05pt" align="justify"><font style="FONT-SIZE: 10pt">Deferred revenues include advances and payments received from customers, for which revenue has not yet been recognized.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 28.35pt; MARGIN: 0in 0in 0pt 56.7pt" align="justify"><font style="FONT-SIZE: 10pt">The Company’s shipping and handling costs are included in cost of revenues.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
	us-gaap	Basis Of Accounting BasisOfAccounting	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="MARGIN-TOP: 0px; FONT: bold 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="TEXT-ALIGN: left; WIDTH: 0.79in"> <div>NOTE 3:-</div> </td> <td style="TEXT-ALIGN: justify"> <div>UNAUDITED INTERIM FINANCIAL STATEMENTS</div> </td> </tr> </table> <font style="FONT-SIZE: 10pt"> </font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 56.7pt" align="justify"><font style="FONT-SIZE: 10pt">The accompanying unaudited interim consolidated financial statements as of June 30, 2015, have been prepared in accordance with U.S. generally accepted accounting principles and standards of the Public Company Accounting Oversight Board for interim financial information. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles in the United States for complete financial statements. In the opinion of management, the unaudited interim consolidated financial statements include all adjustments of a normal recurring nature necessary for a fair presentation of the Company's consolidated financial position as of June 30, 2015, and the Company's consolidated results of operations and the Company's consolidated cash flows for the six months ended June 30, 2015. Results for the six months ended June 30, 2015 are not necessarily indicative of the results that may be expected for the year ending December 31, 2015.</font></div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

Files In Submission

Name	View Source	Status
0001144204-15-048544-index-headers.html	Edgar Link	pending
0001144204-15-048544-index.html	Edgar Link	pending
0001144204-15-048544.txt	Edgar Link	pending
0001144204-15-048544-xbrl.zip	Edgar Link	pending
drio-20150630.xml	Edgar Link	completed
drio-20150630.xsd	Edgar Link	pending
drio-20150630_cal.xml	Edgar Link	unprocessable
drio-20150630_def.xml	Edgar Link	unprocessable
drio-20150630_lab.xml	Edgar Link	unprocessable
drio-20150630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v416505_10q.htm	Edgar Link	pending
v416505_ex10-3.htm	Edgar Link	pending
v416505_ex14-1.htm	Edgar Link	pending
v416505_ex3-1.htm	Edgar Link	pending
v416505_ex3-2.htm	Edgar Link	pending
v416505_ex31-1.htm	Edgar Link	pending
v416505_ex31-2.htm	Edgar Link	pending
v416505_ex32-1.htm	Edgar Link	pending
v416505_ex32-2.htm	Edgar Link	pending
v416505_ex4-2.htm	Edgar Link	pending
v416505_ex4-3.htm	Edgar Link	pending
v416505_ex4-4.htm	Edgar Link	pending
v416505_ex4-5.htm	Edgar Link	pending
v416505_ex4-6.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DRIO
DarioHealth Corp. Stock $drio

2015 Q2 Form 10-Q Financial Statement

#000114420415048544 Filed on August 12, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DRIO DarioHealth Corp. Stock $drio

2015 Q2 Form 10-Q Financial Statement

#000114420415048544 Filed on August 12, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DRIO
DarioHealth Corp. Stock $drio